The Fed's Impossible Position: War Inflation vs. Rate Cuts

**Justin Klein** (0:00)
Do you ever think about how two people can be the same age, yet one just seems to have more energy, gets better sleep, and recovers faster?
That difference usually is less to do with actual age, and more to do with what's happening underneath the surface.
That's why I'm excited to share the good news about the TruAge test from TruDiagnostic. It's an at-home test that looks at markers on your DNA using epigenetics to determine your biological age, not just how many birthdays you've had. Here's what brings the value to the TruAge test. It doesn't stop at a single age number. You get your biological age, your pace of aging, and a breakdown of how 11 key organ systems are aging, including your heart, brain, lungs, and liver. You also get 75 plus longevity biomarkers translated into clear, easy to understand insights around things like metabolic health and immune function. So instead of just getting raw data, you actually get a more complete picture of how your body is functioning day to day. You get personalized recommendations based on your results, things like sleep, nutrition, exercise, supplements, and lifestyle changes.
So you have a clear roadmap for improving your health over time. The process itself is very simple. It's just an at-home finger prick. You send it back in the prepaid kit, and in about two to three weeks you get your full report online. So if you're serious about longevity, or even just curious whether your body is aging faster or slower than your actual age, this is one of the easiest ways to find out. Right now, go to trudiagnostic.com and use code INVEST20 for 20% off your entire order. That's trudiagnostic.com, code INVEST20 for 20% off.

**SPEAKER_2** (1:47)
This is Invest Talk from KPP Financial, helping investors make sense of the markets one day at a time. Here's your host, Justin Klein.

**Justin Klein** (2:01)
Good afternoon and welcome back to the latest edition of Invest Talk. This is our Friday, July 24th, 2026 edition. I'm excited for this hour with you to close out a very interesting week. A week of a lot of big earnings announcements, continued geopolitical volatility, commodity volatility, bond market volatility. Not talked about as much, but definitely a lot of that. So a big week that we just finished up, and I'm here to close it out strong with you. But just like every show, our goal is to answer your finance and investment questions, and to the end, make you a better investor.
So that you can take the data and perspective back to your own personal situation, not rely on just me or Luke or really any one person, except yourself, yourself, so that you can make better decisions consistently. Not just one time, not here to get a tip. It's about learning the principles of good, sound financial management.
Now, just a bit, I'm going to talk about today's market performance, and run down the show topics. But first, let's tackle this caller question now.

**SPEAKER_3** (3:18)
Hey, Justin and Luke.

**Justin** (3:19)
This is Justin here in Colorado.

**SPEAKER_3** (3:21)
I was looking at Cameco, Charlie, Charlie, Juliet.

**SPEAKER_5** (3:24)
I was interested in buying it.

**Eric** (3:25)
It looks like it's come down over the past couple months.

**Justin** (3:29)
I wanted to see if they thought this is a good investment.

**Eric** (3:31)
Thanks for the show.

**Justin Klein** (3:33)
All right. Looking at Cameco, CCJ is the symbol, domestic symbol, so Toronto or it's on the Toronto Exchange, but also listed on the NYSE.
The second largest uranium miner, but really the largest uranium miner that you can purchase easily on major exchanges here. They also bought Westinghouse Electric Company, which provides nuclear reactors. They bought it on bankruptcy some years ago. It's no longer just a pure play uranium company. That gives it a bit of diversity, especially in an age when the demand for energy is just going up and up and up with AI, and obviously domestic energy consumption rising for increased industrial demand, and not just AI, right? Restoring manufacturing, for example.
What's interesting here is that Westinghouse is about 50% of its revenue. Now, however, it's still about only 5% of its operating income.
So yes, it has a lot of revenue there, but uranium is still what makes the bulk of their money. So understand that. It has come down. What's the name we've owned for clients for a long time? I think since the 20s, when it was in the 20s.
It's at 87 now, but it's after a high of 135 just earlier this year. So definitely a large pullback, but I think it is at good support here. So this is an area that we, you know, we've been patient really for most of the year to pick it up for new clients. And we just recently started picking it up for new clients. Long-term, very bullish on uranium.